Glenmark Pharmaceuticals informs about press release

21 Jan 2016 Evaluate

Glenmark Pharmaceuticals has informed about a Press Release dated January 21, 2016 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Potassium Chloride Extended-Release Capsules USP, 10 mEq’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1981.50 -11.20 (-0.56%)
29-Jan-2026 15:24 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1587.55
Dr. Reddys Lab 1207.70
Cipla 1320.60
Zydus Lifesciences 890.75
Lupin 2125.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×